APP and Alzheimer disease: Similarly, using reconstituted membrane preparations from human brain samples, Mahlapuu et al. (2003) found that the induction of G protein activity by APP-derived peptides was significantly reduced in post-mortem elderly AD patients compared to age-matched controls.